{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* Preferably, a monovalent amino acid sequence of the invention (or a polypeptide that contains only one amino acid sequence of the invention) is preferably such that it will bind to growth factor receptors with an affinity less than 500 nM, preferably less than 200 nM, more preferably less than 10 nM, such as less than 500 pM.\n* In particular, amino acid sequences and polypeptides of the invention are preferably such that they: a) bind to growth factor receptors with a dissociation constant (K<sub>D</sub>) of 10<sup>\u22125 </sup>to 10<sup>\u221212 </sup>moles/liter or less, and preferably 10<sup>\u22127 </sup>to 10<sup>\u221212 </sup>moles/liter or less and more preferably 10<sup>\u22128 </sup>to 10<sup>\u221212 </sup>moles/liter (i.e. with an association constant (K<sub>A</sub>) of 10<sup>5 </sup>to 10<sup>12 </sup>liter/moles or more, and preferably 10<sup>7 </sup>to 10<sup>12 </sup>liter/moles or more and more preferably 10<sup>8 </sup>to 10<sup>12 </sup>liter/moles); \n* and/or such that they:b) bind to growth factor receptors with a k<sub>on</sub>-rate of between 10<sup>2 </sup>M<sup>\u22121</sup>s<sup>\u22121 </sup>to about 10<sup>7 </sup>M<sup>\u22121</sup>s<sup>\u22121</sup>, preferably between 10<sup>3 </sup>M<sup>\u22121</sup>s<sup>\u22121 </sup>and 10<sup>7 </sup>M<sup>\u22121</sup>s<sup>\u22121</sup>, more preferably between 10<sup>4 </sup>M<sup>\u22121</sup>s<sup>\u22121 </sup>and 10<sup>7 </sup>M<sup>\u22121</sup>s<sup>\u22121</sup>, such as between 10<sup>5 </sup>M<sup>\u22121</sup>s<sup>\u22121 </sup>and 10<sup>7 </sup>M<sup>\u22121</sup>s<sup>\u22121</sup>;\n* and/or such that they:c) bind to growth factor receptors with a k<sub>off </sub>rate between 1 s<sup>\u22121 </sup>(t<sub>1/2</sub>2=0.69 s) and 10<sup>\u22126 </sup>s<sup>\u22121 </sup>(providing a near irreversible complex with a t<sub>1/2 </sub>of multiple days), preferably between 10<sup>\u22122 </sup>s<sup>\u22121 </sup>and 10<sup>\u22126 </sup>s<sup>\u22121</sup>, more preferably between 10<sup>\u22123 </sup>s<sup>\u22121 </sup>and 10<sup>\u22126 </sup>s<sup>\u22121</sup>, such as between 10<sup>\u22124 </sup>s<sup>\u22121 </sup>and 10<sup>\u22126 </sup>s<sup>\u22121</sup>."}
{"final_json": [{"molecule_name": "amino acid sequence of the invention", "protein_target_name": "growth factor receptors", "binding_metric": "affinity", "value": "< 500 nM", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "amino acid sequence of the invention", "protein_target_name": "growth factor receptors", "binding_metric": "affinity", "value": "< 200 nM", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "amino acid sequence of the invention", "protein_target_name": "growth factor receptors", "binding_metric": "affinity", "value": "< 10 nM", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "amino acid sequence of the invention", "protein_target_name": "growth factor receptors", "binding_metric": "affinity", "value": "< 500 pM", "unit": "pM", "is_logarithmic": false}, {"molecule_name": "amino acid sequences and polypeptides of the invention", "protein_target_name": "growth factor receptors", "binding_metric": "Kd", "value": "10^\u22125 to 10^\u221212", "unit": "moles/liter", "is_logarithmic": false}, {"molecule_name": "amino acid sequences and polypeptides of the invention", "protein_target_name": "growth factor receptors", "binding_metric": "Kd", "value": "10^\u22127 to 10^\u221212", "unit": "moles/liter", "is_logarithmic": false}, {"molecule_name": "amino acid sequences and polypeptides of the invention", "protein_target_name": "growth factor receptors", "binding_metric": "Kd", "value": "10^\u22128 to 10^\u221212", "unit": "moles/liter", "is_logarithmic": false}, {"molecule_name": "amino acid sequences and polypeptides of the invention", "protein_target_name": "growth factor receptors", "binding_metric": "Ka", "value": "10^5 to 10^12", "unit": "liter/moles", "is_logarithmic": false}, {"molecule_name": "amino acid sequences and polypeptides of the invention", "protein_target_name": "growth factor receptors", "binding_metric": "Ka", "value": "10^7 to 10^12", "unit": "liter/moles", "is_logarithmic": false}, {"molecule_name": "amino acid sequences and polypeptides of the invention", "protein_target_name": "growth factor receptors", "binding_metric": "Ka", "value": "10^8 to 10^12", "unit": "liter/moles", "is_logarithmic": false}, {"molecule_name": "amino acid sequences and polypeptides of the invention", "protein_target_name": "growth factor receptors", "binding_metric": "kon-rate", "value": "10^2 to 10^7", "unit": "M^\u22121s^\u22121", "is_logarithmic": false}, {"molecule_name": "amino acid sequences and polypeptides of the invention", "protein_target_name": "growth factor receptors", "binding_metric": "kon-rate", "value": "10^3 to 10^7", "unit": "M^\u22121s^\u22121", "is_logarithmic": false}, {"molecule_name": "amino acid sequences and polypeptides of the invention", "protein_target_name": "growth factor receptors", "binding_metric": "kon-rate", "value": "10^4 to 10^7", "unit": "M^\u22121s^\u22121", "is_logarithmic": false}, {"molecule_name": "amino acid sequences and polypeptides of the invention", "protein_target_name": "growth factor receptors", "binding_metric": "kon-rate", "value": "10^5 to 10^7", "unit": "M^\u22121s^\u22121", "is_logarithmic": false}, {"molecule_name": "amino acid sequences and polypeptides of the invention", "protein_target_name": "growth factor receptors", "binding_metric": "koff-rate", "value": "1 to 10^\u22126", "unit": "s^\u22121", "is_logarithmic": false}, {"molecule_name": "amino acid sequences and polypeptides of the invention", "protein_target_name": "growth factor receptors", "binding_metric": "koff-rate", "value": "10^\u22122 to 10^\u22126", "unit": "s^\u22121", "is_logarithmic": false}, {"molecule_name": "amino acid sequences and polypeptides of the invention", "protein_target_name": "growth factor receptors", "binding_metric": "koff-rate", "value": "10^\u22123 to 10^\u22126", "unit": "s^\u22121", "is_logarithmic": false}, {"molecule_name": "amino acid sequences and polypeptides of the invention", "protein_target_name": "growth factor receptors", "binding_metric": "koff-rate", "value": "10^\u22124 to 10^\u22126", "unit": "s^\u22121", "is_logarithmic": false}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* Typically, antigen-binding proteins (such as the amino acid sequences, Nanobodies and/or polypeptides of the invention) will bind to their antigen with a dissociation constant (K<sub>D</sub>) of 10<sup>\u22125 </sup>to 10<sup>\u221212 </sup>moles/liter or less, and preferably 10<sup>\u22127 </sup>to 10<sup>\u221212 </sup>moles/liter or less and more preferably 10<sup>\u22128 </sup>to 10<sup>\u221212 </sup>moles/liter (i.e. with an association constant (K<sub>A</sub>) of 10<sup>5 </sup>to 10<sup>12 </sup>liter/moles or more, and preferably 10<sup>7 </sup>to 10<sup>12 </sup>liter/moles or more and more preferably 10<sup>8 </sup>to 10<sup>12 </sup>liter/moles).\n* Any K<sub>D </sub>value greater than 10<sup>4 </sup>mol/liter (or any K<sub>A </sub>value lower than 10<sup>4 </sup>M<sup>\u22121</sup>) liters/mol is generally considered to indicate non-specific binding.\n* Preferably, a monovalent immunoglobulin sequence of the invention will bind to the desired antigen with an affinity less than 500 nM, preferably less than 200 nM, more preferably less than 10 nM, such as less than 500 pM."}
{"final_json": [{"molecule_name": "antigen-binding proteins (such as the amino acid sequences, Nanobodies and/or polypeptides of the invention)", "protein_target_name": "antigen", "binding_metric": "Kd", "value": "10\u22125 to 10\u221212", "unit": "moles/liter", "is_logarithmic": false}, {"molecule_name": "antigen-binding proteins (such as the amino acid sequences, Nanobodies and/or polypeptides of the invention)", "protein_target_name": "antigen", "binding_metric": "Kd", "value": "10\u22127 to 10\u221212", "unit": "moles/liter", "is_logarithmic": false}, {"molecule_name": "antigen-binding proteins (such as the amino acid sequences, Nanobodies and/or polypeptides of the invention)", "protein_target_name": "antigen", "binding_metric": "Kd", "value": "10\u22128 to 10\u221212", "unit": "moles/liter", "is_logarithmic": false}, {"molecule_name": "antigen-binding proteins (such as the amino acid sequences, Nanobodies and/or polypeptides of the invention)", "protein_target_name": "antigen", "binding_metric": "Ka", "value": "10^5 to 10^12", "unit": "liter/moles", "is_logarithmic": false}, {"molecule_name": "antigen-binding proteins (such as the amino acid sequences, Nanobodies and/or polypeptides of the invention)", "protein_target_name": "antigen", "binding_metric": "Ka", "value": "10^7 to 10^12", "unit": "liter/moles", "is_logarithmic": false}, {"molecule_name": "antigen-binding proteins (such as the amino acid sequences, Nanobodies and/or polypeptides of the invention)", "protein_target_name": "antigen", "binding_metric": "Ka", "value": "10^8 to 10^12", "unit": "liter/moles", "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": null, "binding_metric": "Kd", "value": ">10^4", "unit": "mol/liter", "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": null, "binding_metric": "Ka", "value": "<10^4", "unit": "M\u22121", "is_logarithmic": false}, {"molecule_name": "monovalent immunoglobulin sequence of the invention", "protein_target_name": "desired antigen", "binding_metric": "affinity", "value": "<500", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "monovalent immunoglobulin sequence of the invention", "protein_target_name": "desired antigen", "binding_metric": "affinity", "value": "<200", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "monovalent immunoglobulin sequence of the invention", "protein_target_name": "desired antigen", "binding_metric": "affinity", "value": "<10", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "monovalent immunoglobulin sequence of the invention", "protein_target_name": "desired antigen", "binding_metric": "affinity", "value": "<500", "unit": "pM", "is_logarithmic": false}]}
{"raw_mentions": "According to a non-limiting but preferred aspect of the invention, (the CDR sequences present in) the Nanobodies of the invention are such that: the Nanobodies can bind to growth factor receptors with a dissociation constant (K<sub>D</sub>) of 10<sup>\u22125 </sup>to 10<sup>\u221212 </sup>moles/liter or less, and preferably 10<sup>\u22127 </sup>to 10<sup>\u221212 </sup>moles/liter or less and more preferably 10<sup>\u22128 </sup>to 10<sup>\u221212 </sup>moles/liter (i.e. with an association constant (K<sub>A</sub>) of 10<sup>5 </sup>to 10<sup>12 </sup>liter/moles or more, and preferably 10<sup>7 </sup>to 10<sup>12 </sup>liter/moles or more and more preferably 10<sup>8 </sup>to 10<sup>12 </sup>liter/moles).\nPreferably, (the CDR sequences present in) the Nanobodies of the invention are such that: a monovalent Nanobody of the invention (or a polypeptide that contains only one Nanobody of the invention) is preferably such that it will bind to growth factor receptors with an affinity less than 500 nM, preferably less than 200 nM, more preferably less than 10 nM, such as less than 500 pM."}
{"final_json": [{"molecule_name": "Nanobodies", "protein_target_name": "growth factor receptors", "binding_metric": "Kd", "value": "10\u22125 to 10\u221212", "unit": "moles/liter", "is_logarithmic": false}, {"molecule_name": "Nanobodies", "protein_target_name": "growth factor receptors", "binding_metric": "Kd", "value": "10\u22127 to 10\u221212", "unit": "moles/liter", "is_logarithmic": false}, {"molecule_name": "Nanobodies", "protein_target_name": "growth factor receptors", "binding_metric": "Kd", "value": "10\u22128 to 10\u221212", "unit": "moles/liter", "is_logarithmic": false}, {"molecule_name": "Nanobodies", "protein_target_name": "growth factor receptors", "binding_metric": "Ka", "value": "10^5 to 10^12", "unit": "liter/moles", "is_logarithmic": false}, {"molecule_name": "Nanobodies", "protein_target_name": "growth factor receptors", "binding_metric": "Ka", "value": "10^7 to 10^12", "unit": "liter/moles", "is_logarithmic": false}, {"molecule_name": "Nanobodies", "protein_target_name": "growth factor receptors", "binding_metric": "Ka", "value": "10^8 to 10^12", "unit": "liter/moles", "is_logarithmic": false}, {"molecule_name": "monovalent Nanobody", "protein_target_name": "growth factor receptors", "binding_metric": "affinity", "value": "<500", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "monovalent Nanobody", "protein_target_name": "growth factor receptors", "binding_metric": "affinity", "value": "<200", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "monovalent Nanobody", "protein_target_name": "growth factor receptors", "binding_metric": "affinity", "value": "<10", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "monovalent Nanobody", "protein_target_name": "growth factor receptors", "binding_metric": "affinity", "value": "<500", "unit": "pM", "is_logarithmic": false}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nPolypeptides comprising one or more Nanobodies of the invention are preferably such that they: bind to growth factor receptors with a dissociation constant (K\u2093D) of 10\u207b\u2075 to 10\u207b\u00b9\u00b2 moles/liter or less, and preferably 10\u207b\u2077 to 10\u207b\u00b9\u00b2 moles/liter or less and more preferably 10\u207b\u2078 to 10\u207b\u00b9\u00b2 moles/liter (i.e. with an association constant (K\u2090) of 10\u2075 to 10\u00b9\u00b2 liter/moles or more, and preferably 10\u2077 to 10\u00b9\u00b2 liter/moles or more and more preferably 10\u2078 to 10\u00b9\u00b2 liter/moles);\nsuch that they: a) bind to growth factor receptors with a k\u2092\u2099-rate of between 10\u00b2 M\u207b\u00b9s\u207b\u00b9 to about 10\u2077 m\u207b\u00b9s\u207b\u00b9, preferably between 10\u00b3 M\u207b\u00b9s\u207b\u00b9 and 10\u2077 M\u207b\u00b9s\u207b\u00b9, more preferably between 10\u2074 M\u207b\u00b9s\u207b\u00b9 and 10\u2077 M\u207b\u00b9 s\u207b\u00b9, such as between 10\u2075 M\u207b\u00b9s\u207b\u00b9 and 10\u2077 M\u207b\u00b9s\u207b\u00b9;\nand/or such that they: b) bind to growth factor receptors with a k\u2092\u209c\u209c rate between 1 s\u207b\u00b9 (t\u2081/\u2082=0.69 s) and 10\u207b\u2076 s\u207b\u00b9 (providing a near irreversible complex with a t\u2081\u2082 of multiple days), preferably between 10\u207b\u00b2 s\u207b\u00b9 and 10\u207b\u2076 s\u207b\u00b9, more preferably between 10\u207b\u00b3 s\u207b\u00b9 and 10\u207b\u2076 s\u207b\u00b9, such as between 10\u207b\u2074 s\u207b\u00b9 and 10\u207b\u2076 s\u207b\u00b9."}
{"final_json": [{"molecule_name": "Nanobodies", "protein_target_name": "growth factor receptors", "binding_metric": "K\u2093D", "value": "10\u207b\u2075 to 10\u207b\u00b9\u00b2", "unit": "moles/liter", "is_logarithmic": false}, {"molecule_name": "Nanobodies", "protein_target_name": "growth factor receptors", "binding_metric": "K\u2093D", "value": "10\u207b\u2077 to 10\u207b\u00b9\u00b2", "unit": "moles/liter", "is_logarithmic": false}, {"molecule_name": "Nanobodies", "protein_target_name": "growth factor receptors", "binding_metric": "K\u2093D", "value": "10\u207b\u2078 to 10\u207b\u00b9\u00b2", "unit": "moles/liter", "is_logarithmic": false}, {"molecule_name": "Nanobodies", "protein_target_name": "growth factor receptors", "binding_metric": "K\u2090", "value": "10\u2075 to 10\u00b9\u00b2", "unit": "liter/moles", "is_logarithmic": false}, {"molecule_name": "Nanobodies", "protein_target_name": "growth factor receptors", "binding_metric": "K\u2090", "value": "10\u2077 to 10\u00b9\u00b2", "unit": "liter/moles", "is_logarithmic": false}, {"molecule_name": "Nanobodies", "protein_target_name": "growth factor receptors", "binding_metric": "K\u2090", "value": "10\u2078 to 10\u00b9\u00b2", "unit": "liter/moles", "is_logarithmic": false}, {"molecule_name": "Nanobodies", "protein_target_name": "growth factor receptors", "binding_metric": "k\u2092\u2099-rate", "value": "10\u00b2 to 10\u2077", "unit": "M\u207b\u00b9s\u207b\u00b9", "is_logarithmic": false}, {"molecule_name": "Nanobodies", "protein_target_name": "growth factor receptors", "binding_metric": "k\u2092\u2099-rate", "value": "10\u00b3 to 10\u2077", "unit": "M\u207b\u00b9s\u207b\u00b9", "is_logarithmic": false}, {"molecule_name": "Nanobodies", "protein_target_name": "growth factor receptors", "binding_metric": "k\u2092\u2099-rate", "value": "10\u2074 to 10\u2077", "unit": "M\u207b\u00b9s\u207b\u00b9", "is_logarithmic": false}, {"molecule_name": "Nanobodies", "protein_target_name": "growth factor receptors", "binding_metric": "k\u2092\u2099-rate", "value": "10\u2075 to 10\u2077", "unit": "M\u207b\u00b9s\u207b\u00b9", "is_logarithmic": false}, {"molecule_name": "Nanobodies", "protein_target_name": "growth factor receptors", "binding_metric": "k\u2092\u209c\u209c rate", "value": "1 to 10\u207b\u2076", "unit": "s\u207b\u00b9", "is_logarithmic": false}, {"molecule_name": "Nanobodies", "protein_target_name": "growth factor receptors", "binding_metric": "k\u2092\u209c\u209c rate", "value": "10\u207b\u00b2 to 10\u207b\u2076", "unit": "s\u207b\u00b9", "is_logarithmic": false}, {"molecule_name": "Nanobodies", "protein_target_name": "growth factor receptors", "binding_metric": "k\u2092\u209c\u209c rate", "value": "10\u207b\u00b3 to 10\u207b\u2076", "unit": "s\u207b\u00b9", "is_logarithmic": false}, {"molecule_name": "Nanobodies", "protein_target_name": "growth factor receptors", "binding_metric": "k\u2092\u209c\u209c rate", "value": "10\u207b\u2074 to 10\u207b\u2076", "unit": "s\u207b\u00b9", "is_logarithmic": false}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nPreferably, the CDR sequences and FR sequences in the Nanobodies of the invention are such that the Nanobodies of the invention (and polypeptides of the invention comprising the same): bind to growth factor receptors with a dissociation constant (K<sub>D</sub>) of 10<sup>\u22125 </sup>to 10<sup>\u221212 </sup>moles/liter or less, and preferably 10<sup>\u22127 </sup>to 10<sup>\u221212 </sup>moles/liter or less and more preferably 10<sup>\u22128 </sup>to 10<sup>\u221212 </sup>moles/liter (i.e. with an association constant (K<sub>A</sub>) of 10<sup>5 </sup>to 10<sup>12 </sup>liter/moles or more, and preferably 10<sup>7 </sup>to 10<sup>12 </sup>liter/moles or more and more preferably 10<sup>8 </sup>to 10<sup>12 </sup>liter/moles);\n\nand/or such that they: bind to growth factor receptors with a k<sub>on</sub>-rate of between 10<sup>2 </sup>M<sup>\u22121</sup>s<sup>\u22121 </sup>to about 10<sup>7 </sup>M<sup>\u22121</sup>s<sup>\u22121</sup>, preferably between 10<sup>3 </sup>M<sup>\u22121</sup>s<sup>\u22121 </sup>and 10<sup>7 </sup>M<sup>\u22121</sup>s<sup>\u22121</sup>, more preferably between 10<sup>4 </sup>M<sup>\u22121</sup>s<sup>\u22121 </sup>and 10<sup>7 </sup>M<sup>\u22121</sup>s<sup>\u22121</sup>, such as between 10<sup>5 </sup>M<sup>\u22121</sup>s<sup>\u22121 </sup>and 10<sup>7 </sup>M<sup>\u22121</sup>s<sup>\u22121</sup>;\n\nand/or such that they: bind to growth factor receptors with a k<sub>off </sub>rate between 1 s<sup>\u22121 </sup>(t<sub>1/2</sub>=0.69 s) and 10<sup>\u22126 </sup>s<sup>\u22121 </sup>(providing a near irreversible complex with a t<sub>1/2 </sub>of multiple days), preferably between 10<sup>\u22122 </sup>and 10<sup>\u22126 </sup>s<sup>\u22121</sup>, more preferably between 10<sup>\u22123 </sup>s<sup>\u22121 </sup>and 10<sup>\u22126 </sup>s<sup>\u22121</sup>, such as between 10<sup>\u22124 </sup>s<sup>\u22121 </sup>and 10<sup>\u22126 </sup>s<sup>\u22121</sup>"}
{"final_json": [{"molecule_name": "Nanobodies of the invention", "protein_target_name": "growth factor receptors", "binding_metric": "Kd", "value": "10\u22125 to 10\u221212", "unit": "moles/liter", "is_logarithmic": false}, {"molecule_name": "Nanobodies of the invention", "protein_target_name": "growth factor receptors", "binding_metric": "Kd", "value": "10\u22127 to 10\u221212", "unit": "moles/liter", "is_logarithmic": false}, {"molecule_name": "Nanobodies of the invention", "protein_target_name": "growth factor receptors", "binding_metric": "Kd", "value": "10\u22128 to 10\u221212", "unit": "moles/liter", "is_logarithmic": false}, {"molecule_name": "Nanobodies of the invention", "protein_target_name": "growth factor receptors", "binding_metric": "Ka", "value": "10^5 to 10^12", "unit": "liter/moles", "is_logarithmic": false}, {"molecule_name": "Nanobodies of the invention", "protein_target_name": "growth factor receptors", "binding_metric": "Ka", "value": "10^7 to 10^12", "unit": "liter/moles", "is_logarithmic": false}, {"molecule_name": "Nanobodies of the invention", "protein_target_name": "growth factor receptors", "binding_metric": "Ka", "value": "10^8 to 10^12", "unit": "liter/moles", "is_logarithmic": false}, {"molecule_name": "Nanobodies of the invention", "protein_target_name": "growth factor receptors", "binding_metric": "kon-rate", "value": "10^2 to 10^7", "unit": "M\u22121s\u22121", "is_logarithmic": false}, {"molecule_name": "Nanobodies of the invention", "protein_target_name": "growth factor receptors", "binding_metric": "kon-rate", "value": "10^3 to 10^7", "unit": "M\u22121s\u22121", "is_logarithmic": false}, {"molecule_name": "Nanobodies of the invention", "protein_target_name": "growth factor receptors", "binding_metric": "kon-rate", "value": "10^4 to 10^7", "unit": "M\u22121s\u22121", "is_logarithmic": false}, {"molecule_name": "Nanobodies of the invention", "protein_target_name": "growth factor receptors", "binding_metric": "kon-rate", "value": "10^5 to 10^7", "unit": "M\u22121s\u22121", "is_logarithmic": false}, {"molecule_name": "Nanobodies of the invention", "protein_target_name": "growth factor receptors", "binding_metric": "koff rate", "value": "1 to 10\u22126", "unit": "s\u22121", "is_logarithmic": false}, {"molecule_name": "Nanobodies of the invention", "protein_target_name": "growth factor receptors", "binding_metric": "koff rate", "value": "10\u22122 to 10\u22126", "unit": "s\u22121", "is_logarithmic": false}, {"molecule_name": "Nanobodies of the invention", "protein_target_name": "growth factor receptors", "binding_metric": "koff rate", "value": "10\u22123 to 10\u22126", "unit": "s\u22121", "is_logarithmic": false}, {"molecule_name": "Nanobodies of the invention", "protein_target_name": "growth factor receptors", "binding_metric": "koff rate", "value": "10\u22124 to 10\u22126", "unit": "s\u22121", "is_logarithmic": false}]}
{"raw_mentions": "There are no sentences that meet the specified criteria. The text does not contain specific molecule names, bioactivity metrics, numeric values, and units as required."}
{"raw_mentions": "17) An amino acid sequence according to any of the preceding aspects, that can specifically bind to a growth factor receptor with a dissociation constant (K\u2093D) of 10\u207b\u2075 to 10\u207b\u00b9\u00b2 moles/litre or less, and preferably 10\u207b\u2077 to 10\u207b\u00b9\u00b2 moles/litre or less and more preferably 10\u207b\u2078 to 10\u207b\u00b9\u00b2 moles/litre. \n18) An amino acid sequence according to any of the preceding aspects, that can specifically bind to a growth factor receptor with a rate of association (k\u2092n-rate) of between 10\u00b2 M\u207b\u00b9s\u207b\u00b9 to about 10\u2077 M\u207b\u00b9s\u207b\u00b9, preferably between 10\u00b3 M\u207b\u00b9s\u207b\u00b9 and 10\u2077 M\u207b\u00b9s\u207b\u00b9, more preferably between 10\u2074 M\u207b\u00b9s\u207b\u00b9 and 10\u2077 M\u207b\u00b9s\u207b\u00b9, such as between 10\u2075 M\u207b\u00b9s\u207b\u00b9 and 10\u2077 M\u207b\u00b9s\u207b\u00b9. \n19) An amino acid sequence according to any of the preceding aspects, that can specifically bind to a growth factor receptor with a rate of dissociation (k\u2092ff rate) between 1 s\u207b\u00b9 and 10\u207b\u2076 s\u207b\u00b9, preferably between 10\u207b\u00b2 s\u207b\u00b9 and 10\u207b\u2076 s\u207b\u00b9, more preferably between 10\u207b\u00b3 s\u207b\u00b9 and 10\u207b\u2076 s\u207b\u00b9, such as between 10\u207b\u2074 s\u207b\u00b9 and 10\u207b\u2076 s\u207b\u00b9."}
{"final_json": [{"molecule_name": null, "protein_target_name": "growth factor receptor", "binding_metric": "Kd", "value": "10\u207b\u2075 to 10\u207b\u00b9\u00b2", "unit": "moles/litre", "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": "growth factor receptor", "binding_metric": "kon-rate", "value": "10\u00b2 to 10\u2077", "unit": "M\u207b\u00b9s\u207b\u00b9", "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": "growth factor receptor", "binding_metric": "koff rate", "value": "1 to 10\u207b\u2076", "unit": "s\u207b\u00b9", "is_logarithmic": false}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nFIG. 13: Results of WB competition assay with anti PDGFRb nanobodies (1 uM) and PDGF (67 nM) on HeLa cells.\nFIG. 14: Results of WB competition assay with anti PDGFRb nanobodies 53-H8 and 53-A2 (0.1-1 uM) and PDGF (67 nM) on HeLa cells.\nb) FIG. 2: Competition assay (phage ELISA) of selected purified Nanobodies (Nb) at 100 nM concentration.\ne) FIG. 5. Competition assay of selected purified anti PDGFR-beta Nanobodies (Nb) at 50 nM conc."}
{"final_json": [{"molecule_name": "anti PDGFRb nanobodies", "protein_target_name": "PDGFRb", "binding_metric": null, "value": "1", "unit": "uM", "is_logarithmic": false}, {"molecule_name": "anti PDGFRb nanobodies 53-H8 and 53-A2", "protein_target_name": "PDGFRb", "binding_metric": null, "value": "0.1-1", "unit": "uM", "is_logarithmic": false}, {"molecule_name": "PDGF", "protein_target_name": null, "binding_metric": null, "value": "67", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "Nanobodies (Nb)", "protein_target_name": null, "binding_metric": null, "value": "100", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "anti PDGFR-beta Nanobodies (Nb)", "protein_target_name": "PDGFR-beta", "binding_metric": null, "value": "50", "unit": "nM", "is_logarithmic": false}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nThe results are shown in FIG. 2, which shows the competition assay of selected purified Nanobodies (Nb) at 100 nM concentration."}
{"final_json": [{"molecule_name": "Nanobodies (Nb)", "protein_target_name": null, "binding_metric": null, "value": "100", "unit": "nM", "is_logarithmic": false}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\n1.0 ug/ml (80 nM) recombinant human PDGF-BB (R&amp;D Systems #220-BB) was coated in 96 well Maxisorp microtiter plates (Nunc) and blocked with 4% Marvel skimmed milk in PBS.\n1 ug/ml (12 nM) PDGFR\u03b2-Fc chimera was incubated with periplasmic extracts or purified Nanobody."}
{"final_json": [{"molecule_name": "PDGF-BB", "protein_target_name": "PDGF-BB", "binding_metric": null, "value": "80", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "PDGFR\u03b2-Fc", "protein_target_name": "PDGFR\u03b2", "binding_metric": null, "value": "12", "unit": "nM", "is_logarithmic": false}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* For this, purified Nanobodies, were used in an ELISA-based ligand competition setup, where 2.0 ug/ml (129 nM) human FGF (R&D Systems Cat #232-FA/CF) was coated in 96 well Maxisorp microtiter plates (Nunc) and blocked with 4% Marvel skimmed milk in PBS.\n* In parallel, 0.25 ug/ml (1.9 nM) FGFR4-Fc chimera plus 2.5 \u03bcg/ml heparin and 10 mM MgCl\u2082 were incubated with periplasmic extracts or purified Nanobody.\n* Ligand is coated at 129 nM and receptor is added at 3.8 nM."}
{"final_json": [{"molecule_name": "human FGF", "protein_target_name": null, "binding_metric": null, "value": "129", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "FGFR4-Fc chimera", "protein_target_name": null, "binding_metric": null, "value": "1.9", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "Ligand", "protein_target_name": null, "binding_metric": null, "value": "129", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "receptor", "protein_target_name": null, "binding_metric": null, "value": "3.8", "unit": "nM", "is_logarithmic": false}]}
